Primary Health Properties Aktie 30141463 / GB00BYRJ5J14
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
30.07.2026 16:08:13
|
Edison issues report on Primary Health Properties (PHP)
|
Edison Investment Research Limited
London, UK, 30 July 2026
Edison issues report on Primary Health Properties (PHP) Edison issues report on Primary Health Properties (LSE: PHP) Primary Health Properties (PHP) has reported H126 results showing strong earnings growth, supported by the successful combination with Assura and underlying portfolio progress. Adjusted EPS increased 9% to 3.8p, comfortably covering DPS of 3.65p (+3%). PHP is now well into its 30th consecutive year of DPS growth. 92% of the expected £9m Assura cost synergies have been put in place and plans are well advanced to reduce post-transaction leverage back to within the targeted range. Significantly, PHP has now agreed exclusive terms for the establishment of a 50/50 private hospital joint venture (JV) with a global long-term institutional investor. Click here to read the full report. All reports published by Edison are available to download free of charge from its website Edison is authorised and regulated by the Financial Conduct Authority. Edison is not an adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy or sell any securities. For more information, please contact Edison: +44 (0)20 3077 5700 Connect with Edison on:
LinkedIn www.linkedin.com/company/edison-group-/ YouTube www.youtube.com/edisonitv
Dissemination of a CORPORATE NEWS, transmitted by EQS Group. |
2374796 30-Jul-2026
Trading Signals: BB Biotech: Comeback nimmt Fahrt auf
Der heimische Biotech-Investor überzeugt nicht nur mit starken Quartalszahlen: Auch schlägt das Portfolio den Branchenindex deutlich, während die Aktie dem inneren Wert noch hinterherhinkt. Genau darin liegt weiteres Kurspotenzial.
Weiterlesen!Nachrichten zu Primary Health Properties PLC R.E.I.T
|
30.07.26 |
Edison issues report on Primary Health Properties (PHP) (EQS Group) |
Analysen zu Primary Health Properties PLC R.E.I.T
Wabtec, Eli Lilly und Novartis neu im BX Musterportfolio
Im BX Morningcall werden folgende Aktien analysiert und erklärt
✅ Wabtec
✅ Eli Lilly
✅ Novartis
https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside ETF
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
SMI beendet Handel fester -- DAX schliesslich kaum verändert --US-Börsen schliessen mit moderaten Verlusten -- Asiens Börsen letztlich stärkerAnleger am heimischen Aktienmarkt griffen zum Wochenstart zu. Der deutsche Leitindex präsentierte sich ohne klare Impulse. Die US-Börsen gaben nach. Die Börsen in Fernost verbuchten am Montag Gewinne.